Announcements
Sidley Advises Sensi.AI in Its US$31 Million Series B Financing
June 28, 2024
Sidley advised Sensi.AI, a trailblazer in care intelligence, in its US$31 million Series B financing round, co-led by Zeev Ventures and Insight Partners, with continued support from existing investors Entrée Capital, Flint Capital, Jibe Ventures, and Secret Chord Ventures.
The Sidley team was led by Dr. Idan Netser (Emerging Companies and Venture Capital, Tax) and included Jake Funk and David Chriki (Emerging Companies and Venture Capital).
The Sidley team was led by Dr. Idan Netser (Emerging Companies and Venture Capital, Tax) and included Jake Funk and David Chriki (Emerging Companies and Venture Capital).
Contacts
Capabilities
Suggested News & Insights
Sidley Represents Aquestive Therapeutics in Exclusive U.S. Licensing Agreement With Eton PharmaceuticalsOctober 16, 2026Sidley Represents Nous Research in US$90 Million Series B FinancingOctober 12, 2026Sidley Represents GE HealthCare in Its US$945 Million Acquisition of SOFIE BiosciencesOctober 7, 2026Sidley Represents Jiangsu Nhwa Pharmaceutical in Its US$517.5 Million Licensing Transaction With SomniveraSeptember 30, 2026Sidley Represents Bluevine in Its US$340 Million Acquisition by Valley National BankSeptember 28, 2026Sidley Represents Star51 Capital in Its Investment in UltraSight’s US$24 Million FinancingSeptember 25, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory